MPM BioVentures IV GmbH & Co. Beteiligungs KG's Net Worth

Estimate Recalculated Nov 7, 2024 04:47PM EST

Who is MPM BioVentures IV GmbH & Co. Beteiligungs KG

MPM BioVentures IV GmbH & Co. Beteiligungs KG does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PEPLIN INC, TriVascular Technologies, Inc., Syndax Pharmaceuticals Inc, Pacira Pharmaceuticals, Inc., Conatus Pharmaceuticals Inc, Epizyme, Inc., CHIASMA, INC, and MEMORY PHARMACEUTICALS CORP.

SEC CIK

MPM BioVentures IV GmbH & Co. Beteiligungs KG's CIK is 0001412336

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TriVascular Technologies, Inc.

Investor

Updated Apr 23, 2014


Form 4	-96.81%	-55.07M	—	—	Apr 23, 2014	1.81M	Options	—	Apr 22
Form 3	—	—	—	—	Apr 15, 2014	—	—	—	—

Showing 2 results

Syndax Pharmaceuticals Inc

Investor

Updated Mar 09, 2016

View Quote Details


Form 4	—	—	—	—	Mar 09, 2016	2.17M	Options	—	Mar 08
Form 3	—	—	—	—	Mar 02, 2016	—	—	—	—

Showing 2 results

CHIASMA, INC

Investor

Updated Jul 21, 2015


Form 4	-89.05%	-46.20M	—	—	Jul 21, 2015	5.68M	Options	—	Jul 21
Form 3	—	—	—	—	Jul 15, 2015	—	—	—	—

Showing 2 results

Epizyme, Inc.

Investor

Updated Feb 11, 2014


Form 4	-16.20%	-466.67K	$29.25	-$13.65M	Feb 11, 2014	2.41M	Sale	—	Feb 10
Form 4	-65.23%	-5.40M	—	—	Jun 06, 2013	2.88M	Options	—	Jun 05
Form 3	—	—	—	—	May 30, 2013	178.33K	—	—	—

Showing 3 results

Pacira Pharmaceuticals, Inc.

Investor

Updated Mar 13, 2013

View Quote Details


Form 4	-15.20%	-500.00K	$27.86	-$13.93M	Mar 13, 2013	2.79M	Sale	—	Mar 11
Form 4	16.31%	461.54K	$6.50	$3.00M	Nov 22, 2011	3.29M	Purchase	—	Nov 21
Form 4/A	23.36%	535.71K	$7.00	—	Feb 17, 2011	2.83M	Purchase	—	Feb 08
Form 4	23.36%	535.71K	$7.00	—	Feb 10, 2011	2.83M	Purchase	—	Feb 08
Form 3	—	—	—	—	Feb 02, 2011	92.98K	—	—	—

Showing 5 results

PEPLIN INC

Investor

Updated Nov 13, 2009


Form 4	-100.00%	-4.21M	—	—	Nov 13, 2009	—	Disposition	—	Nov 11
Form 4	0.07%	2.25K	$8.11	$18.23K	Feb 12, 2009	3.42M	Purchase	—	Feb 11 - Feb 12
Form 4	0.03%	999.00	$8.00	$7.99K	Feb 10, 2009	3.42M	Purchase	—	Feb 09
Form 4	0.08%	2.65K	$7.80	$20.65K	Feb 06, 2009	3.42M	Purchase	—	Feb 05
Form 4	0.23%	7.71K	$8.04	$61.95K	Jan 27, 2009	3.41M	Purchase	—	Jan 23 - Jan 27
Form 4	0.10%	3.52K	$8.07	$28.37K	Jan 23, 2009	3.41M	Purchase	—	Jan 21 - Jan 22
Form 4	0.29%	9.88K	$8.14	$80.40K	Jan 20, 2009	3.40M	Purchase	—	Jan 15 - Jan 20
Form 4	0.20%	6.91K	$7.03	$48.58K	Jan 15, 2009	3.39M	Purchase	—	Jan 13
Form 3/A	—	—	—	—	Jan 14, 2009	3.39M	—	—	—
Form 3	—	—	—	—	Oct 30, 2008	3.28M	—	—	—

Showing 10 results

Conatus Pharmaceuticals Inc

Investor

Updated Jul 24, 2013

View Quote Details


Form 3	—	—	—	—	Jul 24, 2013	—	—	—	—

Showing 1 results

MEMORY PHARMACEUTICALS CORP

Investor

Updated Jan 05, 2009


Form 4	-100.00%	-14.14M	$0.61	-$8.62M	Jan 05, 2009	—	Disposition	—	Jan 01
Form 3	—	—	—	—	Oct 02, 2007	514.19K	—	—	—
Form 4	—	—	—	—	Oct 02, 2007	14.24M	Acq/Dis	—	Jun 30
Form 4	-0.19%	-27.60K	$2.10	-$57.96K	Sep 18, 2007	14.14M	Sale	—	Sep 14
Form 4	-0.51%	-72.18K	$2.13	-$153.73K	Sep 14, 2007	14.17M	Sale	—	Sep 12 - Sep 13

Showing 5 results